Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats.
Coronary artery occlusion-induced tachyarrhythmias that culminate in ventricular fibrillation are the leading cause of death in developed countries. The intrinsic adenosine receptor system protects the heart from an ischemic insult. Thus the increased functional demands made on the heart during exercise may produce protective adaptations mediated by endogenous adenosine. Therefore, we tested the hypothesis that a single bout of dynamic exercise increases the ventricular arrhythmia threshold (VAT) induced by coronary artery occlusion in conscious hypertensive rats via the intrinsic adenosine receptor system. To test this hypothesis, we recorded the VAT before and on an alternate day after a single bout of dynamic treadmill exercise (12 m/min, 10% grade for 40 min). A single bout of dynamic exercise significantly reduced postexercise arterial pressure (Delta-24 +/- 4 mmHg) and increased VAT (Delta+1.95 +/- 0.31 min). Adenosine receptor blockade with the nonselective adenosine receptor antagonists theophylline or aminophylline (10 mg/kg) attenuated the cardioprotective effects of a single bout of dynamic exercise. Results suggest that strategies that increase myocardial ATP requirements leading to adenosine production provide protection against coronary artery occlusion.
Collins
Heidi L
HL
Department of Physiology, Wayne State University School of Medicine, 540 E. Canfield Ave., Detroit, MI 48201, USA. hcollins@med.wayne.edu
Dicarlo
Stephen E
SE
D000208:Acute Disease; D000222:Adaptation, Physiological / Q000502:physiology; D000818:Animals; D001794:Blood Pressure; D003243:Consciousness; D003324:Coronary Artery Disease / Q000503:physiopathology / Q000517:prevention & control; D006973:Hypertension / Q000503:physiopathology*; D017202:Myocardial Ischemia / Q000503:physiopathology* / Q000517:prevention & control; D005082:Physical Exertion / Q000502:physiology*; D051381:Rats; D018047:Receptors, Purinergic P1 / Q000502:physiology*; D017180:Tachycardia, Ventricular / Q000503:physiopathology* / Q000517:prevention & control
D018047:Receptors, Purinergic P1